Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.69% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Entrada Therapeutics
TRDA
$290M
| $168K | ﹤0.01% |
+12,439
| New | +$218K |
|
3852
Retractable Technologies
RVP
$20.3M
| $168K | ﹤0.01% |
102,264
| – | – |
|
3853
KT
KT
$9.03B
| $167K | ﹤0.01% |
12,335
-399,040
| -97% | -$5.31M |
|
3854
BioAtla
BCAB
$5.73M
| $165K | ﹤0.01% |
400
+137
| +52% | +$56.8K |
|
3855
Rigetti Computing
RGTI
$6.21B
| $165K | ﹤0.01% |
226,134
+98,898
| +78% | +$141K |
|
|
LVOX
3856
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $162K | ﹤0.01% |
54,547
+5,875
| +12% | +$15.5K |
|
3857
Palladyne AI
PDYN
$310M
| $161K | ﹤0.01% |
47,901
| – | – |
|
|
SEMR
3858
DELISTED
Semrush
SEMR
| $161K | ﹤0.01% |
19,785
-8,792
| -31% | -$89.1K |
|
|
CPTN
3859
DELISTED
Cepton, Inc. Common Stock
CPTN
| $160K | ﹤0.01% |
12,604
+3,085
| +32% | +$54.8K |
|
3860
Lantern Pharma
LTRN
$33.6M
| $160K | ﹤0.01% |
26,480
| – | – |
|
|
SA
3861
Seabridge Gold
SA
$3.46B
| $160K | ﹤0.01% |
12,682
-1,645
| -11% | -$19.5K |
|
|
THRD
3862
DELISTED
Third Harmonic Bio
THRD
| $160K | ﹤0.01% |
+37,094
| New | +$621K |
|
3863
FTAI Infrastructure
FIP
$551M
| $159K | ﹤0.01% |
53,973
+17,859
| +49% | +$49.4K |
|
|
EIGR
3864
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $159K | ﹤0.01% |
4,487
-111
| -2% | -$13.3K |
|
|
STLN
3865
Starling Oncology, Inc. Common Stock
STLN
$638M
| $158K | ﹤0.01% |
95,926
+9,414
| +11% | +$26.4K |
|
3866
The Beachbody Company
BODI
$47.6M
| $157K | ﹤0.01% |
5,983
| – | – |
|
3867
Scholar Rock
SRRK
$6.46B
| $155K | ﹤0.01% |
17,125
| – | – |
|
3868
Sadot Group
SDOT
$11.5M
| $155K | ﹤0.01% |
85
-1
| -1% | -$1.04K |
|
|
ADTH
3869
DELISTED
AdTheorent Holding Co
ADTH
| $154K | ﹤0.01% |
93,041
+846
| +0.9% | +$1.63K |
|
|
SUNL
3870
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $154K | ﹤0.01% |
5,986
+2,575
| +75% | +$71.3K |
|
3871
Ovid Therapeutics
OVID
$523M
| $154K | ﹤0.01% |
83,014
-140,474
| -63% | -$239K |
|
|
HIMX
3872
Himax Technologies
HIMX
$2.56B
| $153K | ﹤0.01% |
24,605
+6,746
| +38% | +$42.9K |
|
3873
Tenaya Therapeutics
TNYA
$164M
| $153K | ﹤0.01% |
75,940
| – | – |
|
3874
Instil Bio
TIL
$49.3M
| $152K | ﹤0.01% |
12,063
-215
| -2% | -$10.6K |
|
3875
System1
SST
$17.8M
| $152K | ﹤0.01% |
+3,235
| New | +$166K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.